NanoViricides
NNVC
#10122
Rank
ยฃ16.41 M
Marketcap
ยฃ0.76
Share price
-0.96%
Change (1 day)
-23.46%
Change (1 year)

Market capitalization of NanoViricides (NNVC)

Market cap: ยฃ16.41 Million

As of February 2026 NanoViricides has a market cap of ยฃ16.41 Million. This makes NanoViricides the world's 10122th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NanoViricides from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ16.41 M-13.89%
2025ยฃ19.05 M11.13%
2024ยฃ17.14 M82.36%
2023ยฃ9.4 M-11.72%
2022ยฃ10.65 M-66.46%
2021ยฃ31.76 M41.44%
2020ยฃ22.45 M203.1%
2019ยฃ7.4 M-32.34%
2018ยฃ10.95 M-73.45%
2017ยฃ41.24 M-18.28%
2016ยฃ50.47 M9.62%
2015ยฃ46.04 M-53.41%
2014ยฃ98.82 M-32.14%
2013ยฃ0.14 B214.56%
2012ยฃ46.29 M-21.02%
2011ยฃ58.61 M-55.65%
2010ยฃ0.13 B90.75%
2009ยฃ69.28 M2.17%
2008ยฃ67.81 M189.92%
2007ยฃ23.39 M

End of Day market cap according to different sources

On Feb 25th, 2026 the market cap of NanoViricides was reported to be:

ยฃ15.95 Million
by Nasdaq info icon info icon
ยฃ16.41 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
ยฃ134.83 B 821,528.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ225.95 B 1,376,771.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ92.21 B 561,831.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ88.25 B 537,702.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
ยฃ1.14 B 6,870.88%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
ยฃ1.38 B 8,329.68%๐Ÿ‡บ๐Ÿ‡ธ USA